At the same time, gene set enrichment analysis (GSEA) was carried out, revealing the inhibition of pathways related to the immune response, such as T cell activation, PD-L1 expression, and PD-1 checkpoint in cancer (Figure 2B, Supplementary Figure S2A). The gene discussed is PDCD1; the disease is cancer.